New pharmacological options in the treatment of Alzheimer's disease

被引：2
|
作者：
Kleinova, L. [1 ,2 ]
Cerman, J. [2 ]
Hlavka, J. [3 ]
Hort, J. [2 ]
机构：
[1] 1 LF UK, Vseobecne Lekarstvi, Prague, Czech Republic
[2] Neurol Klin 2 LF UK, Kognitivni Ctr, V Uvalu 84, Prague 15006, Czech Republic
[3] Univ Southern Calif, Schaeffer Ctr Hlth Policy & Econ, Los Angeles, CA USA
来源：
CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE | 2022年 / 85卷 / 06期
关键词：
Alzheimer?s disease; phase three testing  of new drugs; β -amyloid; tau protein; neuroinflammatory theory; ric symptoms; neuroprotection; BETA; TRAMIPROSATE; INHIBITION; GUANFACINE; DEMENTIA; TRIAL;
D O I：
10.48095/cccsnn2022462
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
A new era of innovative treatment options for Alzheimer's disease is emerging. New goals of treatment are being developed with various monoclonal antibodies targeting potentially pathological molecules involved in the pathogenesis of Alzheimer's disease. The aim of this review is to acquaint the reader with new potential drugs, while most of those mentioned in this review are in the third phase of clinical trials.
引用
收藏
页码：462 / 469
页数：8
相关论文
共 50 条
  • [41] What are the Treatment Options for Patients with Severe Alzheimer’s Disease?
    Thierry Voisin
    Emma Reynish
    Florence Portet
    Howard Feldman
    Bruno Vellas
    CNS Drugs, 2004, 18 : 575 - 583
  • [42] Current treatment options for people with Alzheimer's disease in Croatia
    Mimica, Ninoslav
    Presecki, Paola
    CHEMICO-BIOLOGICAL INTERACTIONS, 2010, 187 (1-3) : 409 - 410
  • [43] What are the treatment options for patients with severe Alzheimer's disease?
    Voisin, T
    Reynish, L
    Portet, F
    Feldman, H
    Vellas, B
    CNS DRUGS, 2004, 18 (09) : 575 - 583
  • [44] What's new in Alzheimer's disease treatment? Reasons for optimism about future pharmacologic options
    Shadlen, MF
    Larson, EB
    POSTGRADUATE MEDICINE, 1999, 105 (01) : 109 - 118
  • [45] Non-pharmacological treatment of Alzheimer's disease: an update
    Wang, Shaofen
    Xu, Haochen
    Liu, Guangdong
    Chen, Limei
    FRONTIERS IN AGING NEUROSCIENCE, 2025, 17
  • [46] Current and Emerging Pharmacological Targets for the Treatment of Alzheimer's Disease
    Morsy, Ahmed
    Trippier, Paul C.
    JOURNAL OF ALZHEIMERS DISEASE, 2019, 72 : S145 - S176
  • [47] Pharmacological Treatment of Alzheimer's Disease: Insights fromDrosophila melanogaster
    Cheng, Xingyi
    Song, Chaochun
    Du, Yanjiao
    Gaur, Uma
    Yang, Mingyao
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (13) : 1 - 17
  • [48] Is ACAT a novel pharmacological target for the treatment of Alzheimer's disease?
    Puglielli, L
    DRUGS OF THE FUTURE, 2002, 27 (09) : 863 - 868
  • [49] The pharmacological treatment of behavioral and psychological symptoms of Alzheimer's disease
    Alexopoulos, P.
    Gourzis, P.
    ARCHIVES OF HELLENIC MEDICINE, 2008, 25 (06): : 707 - 719
  • [50] Pharmacological treatment of cognitive deficits in Alzheimer's disease - Reply
    Brodaty, H
    Hecker, JR
    Snowdon, JA
    Green, A
    Ames, DJ
    MEDICAL JOURNAL OF AUSTRALIA, 2002, 176 (06) : 297 - 298
12345